HSBC retained its 'Buy' rating on Apollo and KIMS. It raised the price targets on Rainbow and Aster due to a significant capex cycle for hospitals expected by 2025. The brokerage noted persistent structural drivers for hospital growth in India. Seven hospitals are planning to add 16,000 beds over the next 3 to 5 years.
